
Sign up to save your podcasts
Or


Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
145145 ratings
Noubar Afeyan has started 76 companies over his career. One of those companies is Moderna, the COVID vaccine maker that recently surpassed Merck in market value. Afeyan discusses Moderna’s success and where his firm m, Flagship Pioneering, is looking for its next opportunity.
See omnystudio.com/listener for privacy information.

970 Listeners

2,201 Listeners

1,967 Listeners

2,698 Listeners

1,093 Listeners

2,354 Listeners

948 Listeners

797 Listeners

210 Listeners

151 Listeners

418 Listeners

347 Listeners

292 Listeners

188 Listeners

491 Listeners